Form D · Pharmaceuticals

NUPATHE INC.

Conshohocken, PA · CIK 0001375200

Offering snapshot reported Nov 6, 2012 · SEC filing

Reported sold
$28M
Offering amount: $28M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 23, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 6, 2012Initial$28,000,000No comparison20SEC filing
Aug 8, 2011Initial$1,100,000No comparison1SEC filing
Apr 23, 2010Initial$10,062,500No comparison10SEC filing
Jul 21, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Sep 7, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$1.23M
Finders' fees
$0
Form D file number
021-186575

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Leerink Swann LLC39011Leerink Swann LLC · CRD 39011
MTS Securities, LLC104059MTS Securities, LLC · CRD 104059

Source: Form D, filed Nov 6, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Armando Anido Director, Executive
Michael Cola Director
Jeanne Cunicelli Director
James A. Datin Director
Michael C. Diem Director
John H. Dillon, Ii Director
Bart J. Dunn Executive
William J. Federici Director
Ezra H. Felker Executive
Keith A. Goldan Executive
Suzanne M. Hanlon Executive
Jane H. Hollingsworth Director, Executive
Richard S. Kollender Director
Gary J. Kurtzman Director
Michael F. Marino Executive
Gerald W. Mc Laughlin Executive
Robert P. Roche Director
Terri B. Sebree Executive
Brian J. Sisko Director
Wayne P. Yetter Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
227 Washington Street Suite 200
Conshohocken, PA, 19428